Synagis Tm
Sept. 9, 2024
SYNAGIS (palivizumab) Reimbursement | SYNAGIS CONNECT SYNAGIS (palivizumab) Reimbursement | SYNAGIS CONNECT Summary: NACI update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants, CCDR 48(7/8) - Canada.ca Synagis Tm